The Unforeseen Impact of Alice
The fact is, patent examiners are struggling with the application of 35 USC 101 in light of the Alice decision just as much as everyone else. Greater uncertainty among both patent applicants and patent...
View ArticleRetroactive changes to patent eligibility law suggest patents are not a...
Changing the rules of the game is fundamentally unfair, which would be obvious to everyone if we were talking about football, soccer or playing a board game. Somehow common sense is abandoned when...
View ArticleHow to Fix the Software Patent Mess: Go Back to Basics
If U.S. patent eligibility rules were more clear and predictable, the useful art of software development would be more prevalent. The “notorious computer” of the European Patent Office offers a viable...
View ArticleIs there a future for software patents in an age of software innovation?
Normally when there is a rejection the innovation itself has not been rejected, but rather the particular way in which it has been claimed is found to be unacceptable for one reason or another. The...
View ArticleNaked Emperors: A Supreme Court Patent Tale
The idea that the Supreme Court is at all capable of understanding — let alone deciding — issues of a technical nature is ridiculous. Yet their individual and collective lack of knowledge hasn't...
View ArticleSupreme Court applies stare decisis in patent case
Simply stated, any patent decision from the Supreme Court that cites stare decisis lacks all intellectual credibility given how arbitrarily and capriciously they have ignored their patent own precedent...
View ArticlePatent Persecution
Patent prosecution describes the interaction between applicants and their representatives, and a patent office with regard to a patent, or an application for a patent. (source: Wikipedia). It is a...
View ArticleThe looming patent nightmare facing the pharmaceutical industry
During the last hearing of the House Judiciary Committee there was an attempt to insert language via amendment that would make it impossible for Kyle Bass and others to challenge pharmaceutical patents...
View ArticleThoughts on Ex parte Khvorova
Ex parte Khvorova is the first PTAB decision on patent eligibility in the life sciences. Until now, the PTAB has been remarkably silent on eligibility in life sciences in the midst of significant...
View ArticleAriosa is a Good Example of Outcome-Driven § 101 Decisions
The first and most critical task in most eligibility analysis is carefully and precisely defining the subject matter of the claims as well as the natural phenomenon that is potentially being claimed....
View ArticleFederal Circuit Should Reconsider Ariosa v. Sequenom: The Panel Decision...
As the amici correctly argue, the panel’s decision striking down Sequenom’s noninvasive prenatal test strikes at the very heart of the patent system. Revolutionary diagnostic testing methods that cost...
View ArticlePicking winners and losers based on innovation design is unsound, unwise, and...
On some basic level everything can be characterized as an idea. It is also all too easy for those who are not technically trained to believe, no matter how wrongly, that implementation is a trivial or...
View ArticleAriosa v. Sequenom: Petitioning the Federal Circuit to Reverse Course on...
This is a really important question both with respect to biologics and other interventions and also as the Federal Circuit does work with the Supreme Court’s body of precedents. We have basically two...
View ArticleThe Mayo Framework Does Not Moot Preemption
While Mayo and Alice presented a two-part "framework" to address when a particular claimed invention preempts a "fundamental principle," neither case purported to have that framework replace a...
View ArticleAriosa v. Sequenom: Dire consequences for biomedicine require rehearing en...
The panel decision in this case reads recent Supreme Court precedent to create an existential threat to patent protection for an array of meritorious inventions. It avowedly holds that “groundbreaking”...
View ArticlePTAB Wonderland: Statistics show Alice PTAB interpretation not favorable to...
The United States Supreme Court is commonly known to resolve difficult issues of law. Yet, Alice v. CLS Bank[ii], last year’s unanimous Supreme Court decision, has caused confusion about whether...
View ArticleThe Case for Software Patentability, An Interview with David Kappos
KAPPOS: ''Companies like Microsoft and Apple and GE -- all of whom are members [of the Partnership for American Innovation] along with IBM, Ford, DuPont and Pfizer as well as smaller companies like...
View ArticleIt makes no sense for an algorithm to be unpatentable simply because it is...
KAPPOS: "Back when I was an engineer we saw it in mainframe computers where you’d make an invention and frequently initially the software wasn’t fast enough to be able to run the algorithm. So the...
View ArticleThoughts on Ex parte Boyden
A couple months ago I commented on Ex parte Khvorova, expressing disappointment in its analysis and concern over what this might mean since it is “the first PTAB decision in molecular biology since...
View Article3D Printed Human Organs and the Debate on Applicable Patent Law
3D printed human organs are coming increasingly close to being a reality according to several reports. In addition to potentially saving thousands of lives every year, this ground-breaking technology...
View Article